Dr Harshal Deshmukh H.Deshmukh@hull.ac.uk
Clinical Senior Lecturer in Diabetes
Development of a novel risk prediction and risk stratification score for polycystic ovary syndrome (PCOS)
Deshmukh, Harshal; Papageorgiou, Maria; Kilpatrick, Eric S.; Atkin, Stephen L.; Sathyapalan, Thozhukat
Authors
Maria Papageorgiou
Eric S. Kilpatrick
Stephen L. Atkin
Professor Thozhukat Sathyapalan T.Sathyapalan@hull.ac.uk
Professor of Diabetes, Endocrinology and Metabolism
Abstract
Objective
The aim of this study was to develop a simple phenotypic algorithm that can capture the underlying clinical and hormonal abnormalities to help in the diagnosis and risk stratification of polycystic ovary syndrome (PCOS).
Methods
The study consisted of 111 women with PCOS fulfilling the Rotterdam diagnostic criteria and 67 women without PCOS. A Firth's penalized logistic regression model was used for independent variable section. Model optimism, discrimination and calibration were assessed using bootstrapping, area under the curve (AUC) and Hosmer‐Lemeshow statistics, respectively. The prognostic index (PI) and risk score for developing PCOS were calculated using independent variables from the regression model.
Results
Firth penalized logistic regression model with backward selection identified four independent predictors of PCOS namely free androgen index [β 0.30 (0.12), P = 0.008], 17‐OHP [β = 0.20 (0.01), P = 0.026], anti‐mullerian hormone [AMH; β = 0.04 (0.01) P < 0.0001] and waist circumference [β = 0.08 (0.02), P < 0.0001]. The model estimates indicated high internal validity (minimal optimism on 1000‐fold bootstrapping), good discrimination ability (bias corrected c‐statistic = 0.90) and good calibration (Hosmer‐Lemeshow χ2 = 3.7865). PCOS women with a high‐risk score (q1 + q2 + q3 vs q4) presented with a worse metabolic profile characterized by a higher 2‐hour glucose (P = 0.01), insulin (P = 0.0003), triglycerides (P = 0.0005), C‐reactive protein (P < 0.0001) and low HDL‐cholesterol (P = 0.02) as compared to those with lower risk score for PCOS.
Conclusions
We propose a simple four‐variable model, which captures the underlying clinical and hormonal abnormalities in PCOS and can be used for diagnosis and metabolic risk stratification in women with PCOS.
Citation
Deshmukh, H., Papageorgiou, M., Kilpatrick, E. S., Atkin, S. L., & Sathyapalan, T. (in press). Development of a novel risk prediction and risk stratification score for polycystic ovary syndrome (PCOS). Clinical Endocrinology, 90(1), 162-169. https://doi.org/10.1111/cen.13879
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 13, 2018 |
Online Publication Date | Nov 15, 2018 |
Deposit Date | Oct 20, 2018 |
Publicly Available Date | Nov 16, 2019 |
Journal | Clinical Endocrinology |
Print ISSN | 0300-0664 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 90 |
Issue | 1 |
Pages | 162-169 |
DOI | https://doi.org/10.1111/cen.13879 |
Keywords | 17-OHP; AMH; FAI; PCOS; Risk score |
Public URL | https://hull-repository.worktribe.com/output/1123997 |
Publisher URL | https://onlinelibrary.wiley.com/doi/abs/10.1111/cen.13879 |
Contract Date | Oct 20, 2018 |
Files
Article
(902 Kb)
PDF
Copyright Statement
©2019 The authors
You might also like
Deoxynivalenol biomarkers in the urine of UK vegetarians
(2017)
Journal Article
Assessment of urinary deoxynivalenol biomarkers in UK children and adolescents
(2018)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search